|
⚲
|
| Antigenics Inc /DE/ | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001098972 |
| Sale | 2009-08-04 ($10.0 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 7816744400 |
| Address | 3 Forbes Road Lexington, 02421 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
CYL Fund II AL Vehicle, a series of MV Funds, LP
✚
|
0.0 | |
|
CYL Fund II, a series of MV Funds, LP
✚
|
0.0 | |
|
CyMedica Orthopedics, Inc.
✚
|
0.0 | |
|
Cyrgalis Brett
✚
|
0.0 | |
|
Cyrus HCE Master Holdings, L.P.
✚
|
0.0 | |
|
Cyrus Lucrum Fund, L.P.
✚
|
0.0 | |
|
Cytovia, Inc.
✚
|
0.0 | |
|
Czarnecki Christopher J
✚
|
0.0 | |
|
D2 Pharma Consulting LLC
✚
|
0.0 | |
|
Cygnus Income Opportunity Fund LP
✚
|
0.0 |